Delivery Order SPE2DB20D9135-SPE2DB25FZX55
- Not listed
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at approximately $25.1K for EXPAREL 266 mg/20 mL vials. This award was issued as a firm fixed-price delivery order with an ultimate completion date of August 21, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its small business status. EXPAREL is...
- The Defense Logistics Agency awarded a delivery order valued at $15,063.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 mL vials. This firm fixed-price delivery order, issued on July 30, 2025, with an ultimate completion date of August 20, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The contract carries no...
- The Defense Logistics Agency awarded a $25,106.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 31, 2025, for the supply of EXPAREL 266 mg/20 mL vials. This delivery order, which carries an ultimate completion date of August 21, 2025, represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $500 million through November 2026. The award was made without set-aside designation, allowing DMS Pharmaceutical Group...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,510.63 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025. The delivery order, which will be completed by August 11, 2025, is for 266 mg/20 mL vials of EXPAREL, a local anesthetic medication commonly used in surgical and pain management applications. This award was issued without a set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,510.63 by the Defense Logistics Agency on July 24, 2025, for the supply of Exparel 266 mg/20 ml vials. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a discrete purchase under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA. The award carries no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on July 24, 2025, for the supply of EXPAREL 266 mg/20 mL vials. This firm fixed-price delivery order, valued at $50,212.60, is set to be completed by August 14, 2025, with performance taking place at the company's Park Ridge location. The award carries no set-aside designation, reflecting the contractor's competitive...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $5,021.26 for EXPAREL 1.3% 20ML (10 units) by the Defense Logistics Agency's Medical Supply Chain. The contract was awarded on July 31, 2025, with an ultimate completion date of the same day, and carries no set-aside designation. EXPAREL is a liposomal bupivacaine formulation used for local anesthesia and...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $10,042.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on July 21, 2025. The delivery order is for EXPAREL 266 mg/20 mL vials, a liposomal bupivacaine formulation used for local anesthesia and post-operative pain management. The contract carries no set-aside designation, and DMS Pharmaceutical Group is competing as a small business...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,510.63 for EXPAREL 1.3% 20ML (10 units) on July 22, 2025. The award was made by the Defense Logistics Agency's Medical Supply Chain on a firm fixed-price basis with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499,999,999...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $15,063.78 by the Defense Logistics Agency on July 25, 2025, for the supply of EXPAREL 266 mg/20 ml vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and carries no set-aside designation. This award represents a single delivery order issued under DMS Pharmaceutical...
- SPE2DB20D9135Indefinite Delivery Contract
- SPE2DB20D9135-SPE2DB25FZX55Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,510.63 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. EXPAREL is a liposomal bupivacaine formulation used for local anesthesia and post-operative pain management in surgical settings. The contract utilizes firm fixed-price pricing and carries an ultimate completion date of August 21, 2025. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499.999 billion and valid through November 2026, which enables the issuance of firm fixed-price delivery orders for comprehensive pharmaceutical supplies supporting military healthcare facilities worldwide. DMS Pharmaceutical Group Inc. has demonstrated consistent capability in supplying specialized pharmaceutical products to federal healthcare systems, with no set-aside designation applied to this award. The company leverages its woman-owned small business status to compete effectively in federal procurement while maintaining a robust portfolio of pharmaceutical product deliveries, including prescription medications, biologics, and medical consumables. The Defense Logistics Agency's pharmaceutical procurement through this indefinite delivery contract vehicle streamlines the acquisition process for critical medical supplies necessary to support Department of Defense healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 7/31/25 |